We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
51
Accenture
ACN
$115B
$40.1M 0.75%
448,800
+10,106
+2% +$839K
TYL icon
52
Tyler Technologies
TYL
$15.1B
$38.6M 0.72%
352,881
+158,227
+81% +$16.7M
AGN
53
DELISTED
Allergan Inc
AGN
$38.3M 0.71%
180,322
-14,376
-7% -$2.86M
TROW icon
54
T. Rowe Price
TROW
$24B
$37.7M 0.7%
439,241
-3,520
-0.8% -$287K
ICLR icon
55
Icon
ICLR
$13.1B
$37.3M 0.7%
732,248
-306
-0% -$16.5K
SCU
56
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$36.4M 0.68%
311,402
+42,284
+16% +$4.78M
SUN icon
57
Sunoco
SUN
$14.2B
$36.3M 0.68%
729,559
+254,251
+53% +$11.9M
IDXX icon
58
Idexx Laboratories
IDXX
$42.9B
$36.2M 0.67%
+488,650
New +$34.3M
ECL icon
59
Ecolab
ECL
$80.1B
$35.9M 0.67%
343,053
-23,896
-7% -$2.61M
CRM icon
60
Salesforce
CRM
$206B
$34.5M 0.64%
581,675
-11,964
-2% -$705K
GOOG icon
61
Alphabet (Google) Class C
GOOG
$4.13T
$34M 0.63%
1,286,964
-448,427
-26% -$12M
CAH icon
62
Cardinal Health
CAH
$54.7B
$31.1M 0.58%
385,802
+382,816
+12,820% +$30.2M
CNC icon
63
Centene
CNC
$32.3B
$29M 0.54%
1,118,604
-17,792
-2% -$415K
POT
64
DELISTED
Potash Corp Of Saskatchewan
POT
$28.1M 0.52%
794,815
+279,608
+54% +$9.52M
SLB icon
65
SLB Ltd
SLB
$81.6B
$27.3M 0.51%
319,379
-434,869
-58% -$40M
CLR
66
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$27.1M 0.5%
705,862
-568,933
-45% -$28M
AMAT icon
67
Applied Materials
AMAT
$383B
$27M 0.5%
+1,082,680
New +$24.5M
CVS icon
68
CVS Health
CVS
$119B
$26.3M 0.49%
273,420
+207,961
+318% +$18.3M
SHW icon
69
Sherwin-Williams
SHW
$83.8B
$22.7M 0.42%
+258,888
New +$20.4M
ODFL icon
70
Old Dominion Freight Line
ODFL
$41.5B
$21.9M 0.41%
847,602
+350,763
+71% +$8.7M
CBRE icon
71
CBRE Group
CBRE
$42.6B
$21.1M 0.39%
617,401
+212,077
+52% +$6.78M
MHFI
72
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$21M 0.39%
235,486
+232,361
+7,436% +$20.4M
AAP icon
73
Advance Auto Parts
AAP
$2.63B
$20.5M 0.38%
+128,859
New +$18.9M
CWEN icon
74
Clearway Energy Class C
CWEN
$6.65B
$20.3M 0.38%
+861,250
New +$20M
DISCK
75
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$19.2M 0.36%
569,333
-167,564
-23% -$5.71M

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.